• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前血清C反应蛋白对手术治疗的上尿路尿路上皮癌患者预后的影响。

The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.

作者信息

Saito Kazutaka, Kawakami Satoru, Ohtsuka Yukihiro, Fujii Yasuhisa, Masuda Hitoshi, Kumagai Jiro, Kobayashi Tsuyoshi, Kageyama Yukio, Kihara Kazunori

机构信息

Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

出版信息

BJU Int. 2007 Aug;100(2):269-73. doi: 10.1111/j.1464-410X.2007.06934.x. Epub 2007 May 4.

DOI:10.1111/j.1464-410X.2007.06934.x
PMID:17488302
Abstract

OBJECTIVE

To assess the impact of preoperative C-reactive protein (CRP) levels on the prognosis in patients with upper urinary tract (UUT) urothelial carcinoma (UC) primarily treated surgically, as it is increasingly recognized that a systemic inflammatory response is associated with the prognosis for patients with various malignancies.

PATIENTS AND METHODS

The clinical records of 130 patients treated surgically for UUT-UC were reviewed retrospectively. An elevated CRP was defined as >0.5 mg/dL. Actuarial survival curves were calculated by Kaplan-Meier method, with the difference between curves evaluated using the log-rank test. A multivariate analysis was used to identify prognostic factors, with Cox's proportional hazard model.

RESULTS

The median (range) follow-up was 47 (3-190) months. The preoperative serum CRP level was elevated in 24 patients (23%). There were significant associations between CRP level and haemoglobin concentrations, pathological T stage, tumour grade, lymph node involvement and lymphovascular invasion. The 5-year disease-specific and recurrence-free survival rates of 24 patients with elevated CRP were significantly worse than those of the 106 with no CRP elevation (both P < 0.001). On multivariate analysis, preoperative CRP level, pathological T stage and lymph node involvement were significant prognostic factors for disease-specific and recurrence-free survival.

CONCLUSION

This study indicated that an elevated preoperative CRP level predicts a poor survival in patients with UUT-UC.

摘要

目的

评估术前C反应蛋白(CRP)水平对主要接受手术治疗的上尿路(UUT)尿路上皮癌(UC)患者预后的影响,因为越来越多的人认识到全身炎症反应与各种恶性肿瘤患者的预后相关。

患者与方法

回顾性分析130例接受手术治疗的UUT-UC患者的临床记录。CRP升高定义为>0.5mg/dL。采用Kaplan-Meier法计算精算生存曲线,使用对数秩检验评估曲线之间的差异。采用多变量分析,用Cox比例风险模型确定预后因素。

结果

中位(范围)随访时间为47(3-190)个月。24例患者(23%)术前血清CRP水平升高。CRP水平与血红蛋白浓度、病理T分期、肿瘤分级、淋巴结受累及淋巴管浸润之间存在显著相关性。24例CRP升高患者的5年疾病特异性生存率和无复发生存率显著低于106例CRP未升高患者(均P<0.001)。多变量分析显示,术前CRP水平、病理T分期和淋巴结受累是疾病特异性生存和无复发生存的显著预后因素。

结论

本研究表明,术前CRP水平升高预示UUT-UC患者生存不良。

相似文献

1
The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.术前血清C反应蛋白对手术治疗的上尿路尿路上皮癌患者预后的影响。
BJU Int. 2007 Aug;100(2):269-73. doi: 10.1111/j.1464-410X.2007.06934.x. Epub 2007 May 4.
2
Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.在接受手术治疗的局限性上尿路尿路上皮癌患者中,淋巴管浸润与预后不良独立相关。
J Urol. 2007 Dec;178(6):2291-6; discussion 2296. doi: 10.1016/j.juro.2007.08.019. Epub 2007 Oct 22.
3
Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.术前血清C反应蛋白水平升高预示局限性肾细胞癌患者预后不良。
BJU Int. 2007 Jan;99(1):77-80. doi: 10.1111/j.1464-410X.2006.06497.x. Epub 2006 Sep 6.
4
C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.C反应蛋白水平可预测接受放化疗的肌层浸润性膀胱癌患者的预后。
BJU Int. 2008 Apr;101(8):978-81. doi: 10.1111/j.1464-410X.2007.07408.x. Epub 2008 Jan 10.
5
Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.上尿路尿路上皮癌中淋巴管侵犯的临床意义
BJU Int. 2008 Aug 5;102(5):572-5. doi: 10.1111/j.1464-410X.2008.07749.x. Epub 2008 May 15.
6
Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.uroplakin III表达缺失与上尿路尿路上皮癌患者的不良预后相关。
BJU Int. 2006 Jun;97(6):1322-6. doi: 10.1111/j.1464-410X.2006.06158.x.
7
The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).淋巴管浸润在预测临床局限性上尿路尿路上皮癌(pT1-3cN0M0)预后中的作用
J Urol. 2008 Sep;180(3):879-84; discussion 884-5. doi: 10.1016/j.juro.2008.05.022. Epub 2008 Jul 17.
8
C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.C 反应蛋白:根治性肾输尿管切除术治疗局限性上尿路上皮癌患者生存的生物标志物。
Urol Oncol. 2013 Nov;31(8):1725-30. doi: 10.1016/j.urolonc.2012.05.008. Epub 2012 Nov 8.
9
Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.术前血清钠与接受肾输尿管切除术治疗的上尿路上皮癌患者的癌症特异性生存相关。
Int J Urol. 2013 Jun;20(6):594-601. doi: 10.1111/j.1442-2042.2012.03228.x. Epub 2012 Nov 7.
10
The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.术前血清C反应蛋白对肝细胞癌患者预后的影响。
Cancer. 2005 May 1;103(9):1856-64. doi: 10.1002/cncr.20976.

引用本文的文献

1
Lymphadenectomy in upper tract urothelial carcinoma: Clinical insights and controversies (Review).上尿路尿路上皮癌的淋巴结清扫术:临床见解与争议(综述)
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8970. Epub 2025 Aug 14.
2
Urinary microbiome and urological cancers: a mini review.泌尿系统微生物群与泌尿系统癌症:一篇小型综述。
Front Urol. 2024 Mar 8;4:1367720. doi: 10.3389/fruro.2024.1367720. eCollection 2024.
3
Reply to: Letter to the Editor for the Article "Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma," by Urabe, Fumihik et al.
回复:针对浦部史彦等人所著文章《术前血小板增多症对上尿路尿路上皮癌患者无复发生存率的预后影响》致编辑的信
Ann Surg Oncol. 2024 May;31(5):3565-3566. doi: 10.1245/s10434-024-15166-3. Epub 2024 Mar 11.
4
Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma.术前血小板增多对上尿路上皮癌患者无复发生存率的预后影响。
Ann Surg Oncol. 2024 Apr;31(4):2538-2544. doi: 10.1245/s10434-023-14844-y. Epub 2024 Jan 8.
5
Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives.上尿路尿路上皮癌的淋巴结清扫术:现状与未来展望。
Curr Oncol Rep. 2023 Nov;25(11):1327-1344. doi: 10.1007/s11912-023-01460-y. Epub 2023 Oct 6.
6
Preoperative C-reactive protein is related with renal cell tumor dimension? Preliminary results.术前 C 反应蛋白与肾细胞肿瘤大小有关?初步结果。
Rom J Morphol Embryol. 2022 Oct-Dec;63(4):639-644. doi: 10.47162/RJME.63.4.06.
7
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.帕博利珠单抗治疗转移性尿路上皮癌的预处理临床和血液学预后因素:系统评价和荟萃分析。
Int J Clin Oncol. 2022 Jan;27(1):59-71. doi: 10.1007/s10147-021-02061-0. Epub 2021 Nov 10.
8
Estimated Glomerular Filtration Rate as a Prognostic Factor in Urothelial Carcinoma of the Upper Urinary Tract: A Systematic Review and Meta-Analysis.估计肾小球滤过率作为上尿路尿路上皮癌的预后因素:一项系统评价和荟萃分析
J Clin Med. 2021 Sep 15;10(18):4155. doi: 10.3390/jcm10184155.
9
Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single-center analysis in Japan.帕博利珠单抗治疗转移性尿路上皮癌的疗效和安全性:日本单中心回顾性分析。
Cancer Rep (Hoboken). 2021 Dec;4(6):e1398. doi: 10.1002/cnr2.1398. Epub 2021 May 2.
10
Impact of cachexia on oncologic outcomes of sarcopenic patients with upper tract urothelial carcinoma after radical nephroureterectomy.恶病质对根治性肾输尿管切除术后上尿路尿路上皮癌肌少症患者肿瘤学结局的影响。
PLoS One. 2021 Apr 21;16(4):e0250033. doi: 10.1371/journal.pone.0250033. eCollection 2021.